Home Blog Page 1333

Ocean Tomo Bolsters Radio Frequency, Wireless, and Spectrum Expertise with Addition of Director Dan Sleeter

Sleeter’s background spanning defense, telecommunications, aerospace, and secure mission systems strengthens the firm’s technical leadership in wireless technology reverse engineering and patent claim analysis.

NEW YORK, Feb. 5, 2026 /PRNewswire/ — Global consulting firm J.S. Held announces today that former US Air Force Radio Frequency (RF) systems engineer Dan Sleeter has joined the Patent Analysis and Reverse Engineering group of Ocean Tomo. Sleeter brings more than 15 years of experience leading cross–functional technical teams across AI–driven RF programs, secure cloud environments, and agile delivery models supporting both national defense and commercial clients.

Summary of Dan Sleeter’s Expertise

  • 15+ years leading cross–functional teams across AI–driven RF programs, secure cloud environments, and agile delivery models.
  • Deep expertise in RF systems, spectrum management, acquisition frameworks, and regulatory compliance.
  • Proven success delivering mission–aligned, innovation–driven, and technically rigorous solutions for DoD and commercial clients.
  • Specialized background in NSA secure communications, TEMPEST/EMSEC, classified RF engineering, and RFML/AI–enabled signal analysis.
  • Brings national–security–grade RF insight to patent analysis, reverse engineering, and complex system deconstruction.

Sleeter draws on a strong foundation of U.S. Air Force service and deep hands–on RF engineering expertise to guide clients through complex system evaluations, spectrum challenges, and intellectual property matters. His proven success managing programs for the U.S. Department of Defense (DoD) and commercial stakeholders reflects a commitment to mission alignment, technical rigor, and innovation.

“Dan brings a rare combination of national security–grade RF experience, modern AI/ML capability, and hands-on engineering depth,” said Tim Dorney PhD, Technical Lead, Patent Analysis and Reverse Engineering. “Our clients rely on us for precise, defensible interpretations of highly complex technologies, and Dan’s expertise significantly expands what our team can deliver.”

Sleeter’s expertise spans the full lifecycle of RF systems—design, testing, and maintenance of technologies enabling 4G/5G networks, Wi-Fi, radar, satellite communications, and Bluetooth. His work ensures secure, interference–free communication across telecommunications, aerospace, defense, and consumer electronics industries.

“Dan’s background in secure communications, TEMPEST/EMSEC compliance, and classified RF systems engineering directly enhances our ability to deconstruct modern wireless and sensing technologies,” added Sam Wiley, Strategic Business Intelligence Team Lead, Patent Analysis and Reverse Engineering. “His experience applying RF machine learning and automation to spectrum analysis provides a powerful advantage for our clients facing intricate IP and technical challenges.”

Sleeter has led RF/AI-enabled initiatives to characterize signal behavior, detect interference, and automate spectrum workflows across diverse software-defined radio environments. This hands-on analytical depth translates into detailed, component-level insights when evaluating patent claims, identifying infringement pathways, or mapping system architectures for Ocean Tomo clients.

“As our clients face increasingly sophisticated technologies and equally complex disputes, Dan’s combination of technical excellence and analytical discipline is exactly what our practice needs,” said James E. Malackowski, Ocean Tomo Co-founder, Head of the Intellectual Property Practice, and J.S. Held Chief Intellectual Property Officer. “We are thrilled to welcome him to the team.”

Industry Expertise

Before joining Ocean Tomo, Sleeter served as a Senior Radio Frequency Engineer with:

  • Huntington Ingalls Industries – the largest U.S. military shipbuilding company
  • Alion Science and Technology (now part of HII Mission Technologies) – a leading defense contractor supporting the DoD and intelligence community
  • Silver Spring Network – provider of IoT and smart grid networking technologies

He has also held RF design and testing engineering roles with:

  • Verizon Wireless – a global leader in 5G and fiber-optic communications
  • L-3 Communications (now part of L3Harris) – a major defense contractor specializing in secure communications and advanced electronic systems

Ocean Tomo’s unique understanding of intellectual property (IP) value is driven by the firm’s engagement across all matters involving intangible assets, spanning strategic planning, investments, disputes, and transactions.  Litigation outcomes refine valuation methodologies, while advisory engagements are shaped by real-world insights from both the boardroom and public markets. Transaction outcomes—buying, selling, and licensing IP—validates strategic decisions and informs how IP is valued in practice. Ocean Tomo valuations used by IP owners to access capital provides insight on how financial institutions recognize IP as a bankable asset. This continuous feedback strengthens the team’s ability to deliver credible, actionable insights across all matters involving intangible assets.

About J.S. Held

J.S. Held is a global consulting firm that combines technical, scientific, financial, and strategic expertise to advise clients seeking to realize value and mitigate risk. Our professionals serve as trusted advisors to organizations facing high stakes matters demanding urgent attention, staunch integrity, proven experience, clear-cut analysis, and an understanding of both tangible and intangible assets. The firm provides a comprehensive suite of services, products, and data that enable clients to navigate complex, contentious, and often catastrophic situations.

More than 1,500 professionals serve organizations across six continents, including 84% of the Global 200 Law Firms, 75% of the Forbes Top 20 Insurance Companies (90% of the NAIC Top 50 Property & Casualty Insurers), and 71% of Fortune 100 Companies.

J.S. Held, its affiliates and subsidiaries are not certified public accounting firm(s) and do not provide audit, attest, or any other public accounting services. J.S. Held is not a law firm and does not provide legal advice. Securities offered through PM Securities, LLC, d/b/a Phoenix IB or Ocean Tomo Investments, a part of J.S. Held, member FINRA/SIPC. All rights reserved.

Media Contact

Kristi L. Stathis, J.S. Held, +1 786 833 4864, Kristi.Stathis@JSHeld.com, JSHeld.com

Massimo Group Showcases MVR HVAC Pro Series at the GCSAA Conference, Accelerating Dealer, Fleet and International Expansion

GARLAND, Texas, Feb. 5, 2026 /PRNewswire/ — Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and advanced electric mobility solutions, today announced its participation in the 2026 Golf Course Superintendents Association of America Conference and Trade Show, taking place in Orlando, Florida from February 2 – 5, 2026. The event marks another strategic step in the Company’s ongoing push to expand fleet sales, strengthen its dealer network, and introduce its premium MVR HVAC Pro Series to institutional and commercial customers.

Massimo Group Attends 2026 GCSAA Show
Massimo Group Attends 2026 GCSAA Show

At GCSAA, Massimo will showcase its second-generation MVR HVAC Pro Series, including both the Golf Version, designed for golf course operations and hospitality environments, and the Cargo Max Version, a utility-focused platform built for fleet, maintenance and commercial applications. Both models feature factory-integrated heating and air conditioning within a fully enclosed cab, addressing growing demand for year-round, all-weather electric vehicles in professional settings.

The GCSAA Conference follows three successful industry events already attended by Massimo in 2026 — AIM Expo in California, the PGA Show in Orlando, and the Mid-States Rendezvous — where the Company generated significant commercial interest across its premium HVAC product lineup. Collectively, these events have resulted in more than 100 dealer leads to date, reinforcing expanding demand for Massimo’s differentiated product offerings.

In parallel, the Company reported that January 2026 dealer-channel sales increased more than 150% year-over-year, a strong early-year indicator of accelerating dealer engagement and end-market demand.

Beyond domestic growth, Massimo has also received initial inquiries regarding exclusive distribution rights within the European Union for its MVR HVAC Pro Series. While discussions remain preliminary, the level of international interest underscores the broader global appeal of Massimo’s premium HVAC-equipped electric vehicle platforms as the Company continues to build out its dealer and distribution infrastructure.

“Each industry event we attend further validates our strategy of targeting fleet buyers and professional users with premium, climate-controlled electric vehicles,” said David Shan, CEO of Massimo Group. “The growing dealer interest, strong early-year sales momentum, and emerging international inquiries reinforce our confidence in the long-term growth potential of our HVAC Pro Series as we move into 2026 and beyond.”

Massimo’s continued focus on expanding dealer relationships, penetrating fleet markets, and introducing higher-margin premium products positions the Company to capitalize on increasing demand for reliable, all-weather electric mobility solutions across golf, commercial and utility sectors.

About Massimo Group

Massimo Group (NASDAQ: MAMO) is a U.S.-based manufacturer and distributor of powersports vehicles, utility terrain vehicles (UTVs), electric mobility solutions, and related accessories, serving customers through a nationwide dealer network.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the federal securities laws with respect to Massimo Group. All statements other than statements of historical facts contained in this press release, including statements regarding Massimo Group’s future results of operations and financial position, Massimo Group’s business strategy, prospective costs, timing and likelihood of success, plans and objectives of management for future operations, future results of current and anticipated operations of Massimo Group are forward-looking statements. These include, among others, plans to accelerate dealer, fleet, and international expansion; expected demand and margins for the MVR HVAC Pro Series; preliminary EU exclusive distribution discussions; and references to long‑term growth and January 2026 dealer‑channel momentum. In some cases, forward-looking statements can be identified because they contain words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “predict,” “project,” “target,” “potential,” “seek,” “will,” “would,” “could,” “should,” “continue,” “contemplate,” “plan,” and other words and terms of similar meaning. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to, risks relating to Massimo Group which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth economically and hire and retain key employees; costs; changes in applicable laws or regulations; the possibility that Massimo Group may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties, including those listed under “Risk Factors” in our Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Moreover, Massimo Group operates in very competitive and rapidly changing environments. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond Massimo Group’s control, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements speak only as of the date they are made. No assurance can be given regarding the forward-looking statements, and actual results may differ materially from those as indicated. Massimo Group undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Company Contact

Quenton Petersen
Vice President
Massimo Group
Email: ir@massimomotor.com

Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications

  • NLRP3 is a validated anti-inflammatory target that mediates the release of proinflammatory cytokines IL-1β and IL-18, and ISM5059 targets systemic inflammatory conditions by targeting NLRP3 and blocking the inflammatory cascade at its source.
  • Unlike ISM8969, Insilico’s brain-penetrant NLRP3 pipeline already with FDA IND clearance, ISM5059 features a completely different chemical core designed for peripheral-restricted potency.
  • Empowered by AI, ISM5059 demonstrated robust efficacy, excellent safety profiles in preclinical studies, and low predicted human efficacious dose, with high potential in multiple indications including autoimmune and chronic cardiometabolic diseases with no obvious CNS (central nervous system) related toxicity observed in preclinical studies.

HONG KONG, Feb. 5, 2026 /PRNewswire/ — The NOD-like receptor protein 3 (NLRP3) inflammasome is a validated target for anti-inflammatory drug development. Upon activation by internal and external stimuli, NLRP3 mediates the release of proinflammatory cytokines IL-1β and IL-18, thereby driving a form of inflammatory cell death called pyroptosis. NLRP3 plays an important role in a variety of inflammatory diseases, including metabolic and cardiovascular disorders. Currently, there is a significant unmet clinical need in the treatment of systemic inflammatory diseases, highlighting the urgent demand for innovative drug options with greater efficacy and a wider safety margin.

Insilico Medicine (3696.HK), a clinical-stage, generative AI-driven drug discovery company, today announced the nomination of ISM5059, an AI-empowered, peripherally restricted small molecule inhibitor targeting NLRP3 as preclinical candidate compound (PCC). Guided by Pharma.AI, Insilico’s proprietary generative platform covering the whole cycle of drug discovery, ISM5059 features a novel core structure, was specifically designed to inhibit NLRP3 conformational changes and oligomerization, while maintaining exceptional safety profiles.

“Targeting NLRP3 offers tremendous potential across a pipeline-in-a-drug model. Beyond classic immune and inflammatory diseases, NLRP3 overactivation is a key driver in lifestyle-associated and metabolic disorders such as obesity, hyperlipidemia, diabetes, and cardiovascular disease.” said Feng Ren, Ph.D., Co-CEO and Chief Scientific Officer of Insilico Medicine. “More importantly, ISM5059 comes with peripheral-restricted trait and a novel chemical core structure, demonstrating how generative AI can produce highly potential molecules with desired properties and innovative structures.”

In preclinical studies, ISM5059 has demonstrated high potency and selectivity, favorable safety profiles and excellent in vivo efficacy across animal disease models, supporting broad indication potential expanding into autoimmune and inflammatory diseases, metabolic diseases, cardiovascular diseases and ophthalmology diseases. Moreover, ISM5059 is predicted to be efficacious at a low dose in humans, providing a high safety margin for future validation.

Specifically, in the in vivo peritonitis model, ISM5059 demonstrated a robust, dose-dependent inhibition of Interleukin-1β (IL-1β), a potent pro-inflammatory cytokine as a master regulator of the inflammatory response. Notably, even at the lowest tested dose of 0.3 mg/kg, IL-1β levels were nearly halved compared to the vehicle control group. This was followed by a steep, progressive reduction at higher dose levels, highlighting ISM5059’s high potency in suppressing acute inflammatory responses.

This nomination follows the recent FDA IND approval for Insilico’s other NLRP3 program, ISM8969, a potential best-in-class, brain-penetrant candidate discovered and optimized through Insilico Medicine’s Pharma.AI platform and intended for the treatment Parkinson’s disease. To accelerate the development of ISM8969, Insilico has entered into a co-development collaboration with Hygtia Therapeutics, where both parties hold 50% of the global rights, and Insilico is eligible to receive up to $66 million in upfront and milestone payments.

Harnessing state-of-the-art AI and automation technologies, Insilico has significantly improved the efficiency of preclinical drug development, setting a benchmark for AI-driven drug R&D. While traditional early-stage drug discovery typically requires an average of 4.5 years, Insilico has nominated 20 preclinical candidates from 2021 to 2024, with an average timeline—from project initiation to preclinical candidate (PCC) nomination—of just 12 to 18 months per program, with only 60 to 200 molecules synthesized and tested in each program.

About Insilico Medicine

Insilico Medicine is a pioneering global biotechnology company dedicated to integrating artificial intelligence and automation technologies to accelerate drug discovery, drive innovation in the life sciences, and extend healthy longevity to people on the planet. The company was listed on the Main Board of the Hong Kong Stock Exchange on December 30, 2025, under the stock code 03696.HK.

By integrating AI and automation technologies and deep in-house drug discovery capabilities, Insilico is delivering innovative drug solutions for unmet needs including fibrosis, oncology, immunology, pain, and obesity and metabolic disorders. Additionally, Insilico extends the reach of Pharma.AI across diverse industries, such as advanced materials, agriculture, nutritional products and veterinary medicine. For more information, please visit www.insilico.com 

Providence Therapeutics Announces Appointment of Leah Goodman to the Board of Directors

Leah Goodman brings a wealth of policy and regulatory experience and is a recognized leader in Australia for advancing scientific discoveries to patient impacts.

CALGARY, AB and BRISBANE, Australia, Feb. 5, 2026 /PRNewswire/ — Providence Therapeutics, a Canadian clinical-stage mRNA biotechnology company, supporting a world-first clinical trial evaluating personalized mRNA cancer vaccines for children with advanced and treatment-resistant brain tumors, is pleased to welcome Leah Goodman to the Board of Directors.

Leah Goodman
Leah Goodman

Since late 2023, Leah Goodman has served as Chief Executive Officer of Biointelect, a leading Australian life science consultancy and CRO. She has been involved in supporting early- and late-stage biotechnology companies, as well as all levels of government and research sectors across Australia, the US, Asia, and Europe.  This involvement has led to the commercialization of innovation through strategic thought and implementation which maximizes the speed of patient access. In 2025, through federal government MRFF investment, Biointelect established an incubator to support Australian SME commercialization of vaccine and infectious disease innovations.

Leah has successfully led commercial businesses across Australia, New Zealand, Japan, South Korea and various Southeast Asian markets with Sanofi, Merck KaaG and Bristol Myers Squibb.

She has a depth of experience in commercialization, business development, policy shaping, market access and regulatory affairs across a breadth of therapeutic areas including oncology and immunotherapies, as well as cell and gene therapy advanced GMP manufacturing.  

Leah holds a Bachelor of Science and a Masters Degree in Commerce both from the University of NSW. She is a graduate of the Australian Institute of Company Directors (GAICD) and holds a certificate in advanced GMP manufacturing. Leah is a member of the AusBiotech NSW Leadership Council, BioNSW Commercialization committee, and was previously on the AusBiotech Cell and Gene therapy Policy and Advocacy working group.

“My excitement in joining the Providence Therapeutics Board is based on the opportunity it presents to help shape innovations that can truly transform patient lives. Throughout my career, I’ve seen how powerful scientific breakthroughs become when paired with thoughtful commercialization. Providence’s vision aligns perfectly with my motivation to enable meaningful, accessible innovation. I’m honoured to bring my global leadership experience and deep Australian insight to support the team in delivering life‑changing therapies to patients around the world.”

About Providence Therapeutics:

Founded in 2015 with headquarters in Calgary, Canada Providence Therapeutics Holdings Inc. is a clinical stage platform mRNA company with proprietary technologies and know how including: INTENT™ lipid nanoparticle delivery and expertise in mRNA design and manufacturing. Providence has multiple programs in oncology, infectious disease, and animal health.

For more information visit www.providencetherapeutics.com

Media Contact: media@providencetherapeutics.com

Photo – https://laotiantimes.com/wp-content/uploads/2026/02/providence_therapeutics_holdings_inc_providence_therapeutics_ann.jpg 

DIFC’s landmark 2025 results solidify Dubai’s position as a leading global destination for finance and business

DUBAI, UAE, Feb. 5, 2026 /PRNewswire/ — Dubai International Financial Centre (DIFC) announced landmark annual results that underscore Dubai’s prominence as the leading global financial centre in the Middle East, Africa and South Asia (MEASA) region.

DIFC
DIFC

DIFC’s 28 per cent organic year-on-year growth to 8,844 active registered companies demonstrates global industry confidence in Dubai as the region’s leading destination for finance, business and innovation. Active company registrations surged by 2,525, an increase of 39 per cent from the prior year, while recording 50,200 financial services related professionals. Combined 2025 revenues rose by 20 per cent to USD 581mn, rising from USD 484mn in 2024. Net profits increased by 28 per cent to USD 402mn from USD 315mn in 2024.

DIFC is home to the region’s largest regulated financial services system which comprises 1,052 firms, including banks, capital market institutions, insurance and reinsurance companies, brokerage firms, wealth and asset management entities. Growing at an incomparable pace, DIFC houses over 500 wealth and asset management companies. 

During 2025, new financial services arrivals include Allianz Trade, Cambridge Associates, CapitaLand, China International Capital Corporation, CRDB Bank, dLocal, Howden Reinsurance, ICICI Asset Management, Manulife, National Bank of Kuwait, North Rock Capital, PIMCO, RV Capital, Silver Point Capital, Squarepoint Capital, Starwood Capital, Tourmaline, Turkiye Vakiflar Bankasi, TransAmerica Life Bermuda, Warburg Pincus and many others.

HE Essa Kazim, Governor of DIFC, commented: “DIFC’s progressive legal and regulatory framework form decisive pillars that support the phenomenal growth achieved by the Centre in 2025. Such incremental growth contributes significantly to Dubai’s economy and enhances the Emirate’s stature as a leading global financial centre, in line with national objectives and the strategic ambitions of the Dubai Economic Agenda (D33).”

As the region’s largest innovation-focused community, DIFC reached 1,677 AI and FinTech organisations in 2025. Enabled by DIFC’s Innovation Hub and Dubai AI Campus platform, start-ups have collectively raised in excess of USD 4.5bn regionally.

The Centre is now home to 1,289 family-related entities. DIFC based families have established 1,115 foundations.

Accelerating Dubai’s position as a top four global financial centre, the recently announced Zabeel District expansion adds 17.7mn sq. ft. of office, residential, hospitality, retail, cultural and education space. The development will also continue to enhance DIFC’s reputation for art, culture, dining, retail and wellness.

Video: DIFC 2025 Annual Review

 

DFI Retail Group to Announce 2025 Full Year Financial Results and Host Analyst Presentation Live Webcast

HONG KONG SAR – Media OutReach Newswire – 5 February 2026 – DFI Retail Group Holdings Limited will announce its 2025 Full Year Results after market close on 3 March 2026, followed by an analyst presentation live webcast on 4 March 2026.
Date: Wednesday, 4 March 2026
Time: 09:30-10:30 am (Hong Kong Time)
Presented by: Mr. Scott Price, Group Chief Executive and Mr. Tom van der Lee, Group Chief Financial Officer
Kindly RSVP by completing the form on or before Wednesday, 25 February 2026.
To avoid delays, we encourage participants to log in ten minutes ahead of the scheduled start time. A replay of the presentation will be available via webcast on DFI Retail Group’s website.
Should you have any queries please email us at DFIComms@DFIretailgroup.com.

Hashtag: #DFIRetailGroup #Mannings #Guardian #7-Eleven #Wellcome #MarketPlace #IKEA #yuu

The issuer is solely responsible for the content of this announcement.

About DFI Retail Group

DFI Retail Group (the ‘Group’) is a leading Asian retailer, driven by its purpose to “Sustainably Serve Asia for Generations with Everyday Moments”.

At 1 December 2025, the Group and its associates operated over 7,400 outlets, and employed over 81,000 people across 12 markets.

The Group is dedicated to delivering quality, value and service to Asian consumers through a compelling retail experience, supported by an extensive store network and highly efficient supply chains.

The Group and its associates, operates a portfolio of well-known brands across five key divisions: health and beauty, convenience, food, home furnishings and restaurants.

Iron Software Sees 200% Increase in Agentic AI Adoption for HTML to PDF C# Workflows with IronPDF

A decade of building reliable document processing tools—including the industry-leading IronPDF library for HTML to PDF C# conversion—positions Iron Software at the center of the enterprise AI execution layer

CHICAGO, Feb. 5, 2026 /PRNewswire/ — Iron Software, a leading provider of .NET document processing libraries and creator of IronPDF, today highlighted its strategic position in the rapidly emerging agentic AI landscape. Major consulting firms’ 2026 technology reports confirm what Iron Software has been building toward for a decade: AI agents need reliable, enterprise-grade tools to do real work—and document processing is where that work begins.

Cameron Rimington, CEO and Founder of Iron Software (right):
Cameron Rimington, CEO and Founder of Iron Software (right): “We didn’t predict the AI revolution. But we did predict that enterprises would always need to create PDFs, extract text from images, and manipulate spreadsheets. Now AI agents need to do all of those same things.”

Deloitte’s Tech Trends 2026 report, published December 10, 2025, identifies agentic AI as one of five interconnected forces reshaping enterprise technology, yet cautions that “only 11% have successfully deployed these systems in production.” The report finds that “processes designed for human workers don’t work for agents” and calls for enterprises to rebuild rather than merely enhance their foundations.

PwC’s 2026 AI Business Predictions report reinforces this shift from experimentation to execution, warning that “crowdsourcing AI efforts can create impressive adoption numbers, but it seldom produces meaningful business outcomes.” PwC urges enterprises to “go narrow and deep” on high-value workflows, identifying document-heavy functions like finance, HR, tax, and internal audit as prime candidates for agentic transformation.

The Gap Between Intelligence and Execution

AI agents can reason, plan, and make decisions—but they cannot generate a contract, parse a scanned invoice, or produce a client report without the right tools. Iron Software’s product suite, anchored by IronPDF, provides the execution layer that bridges this gap.

IronPDF enables developers to convert HTML to PDF in C# with a single method call—a capability now in high demand as AI agents automate document generation workflows across enterprise environments. When an agent determines that a financial report needs to be created or a customer-facing proposal needs to be rendered, it is libraries like IronPDF that perform the actual work. The broader Iron Software suite—including IronOCR, IronXL, and IronBarcode—extends this execution layer across the full spectrum of enterprise document tasks.

“AI agents are only as capable as the tools they can call upon,” said Jacob Mellor, CTO of Iron Software. “Consider a common enterprise workflow: an AI agent needs to pull data from a spreadsheet, generate an HTML report, and convert HTML to PDF in C# for distribution. That agent needs IronXL to read the data and IronPDF to render the final document—reliably, every single time, at scale. When Deloitte reports that enterprises are struggling to move AI from pilots to production, a significant part of that challenge is infrastructure. We’ve spent ten years building exactly that.”

A Decade of Building for This Moment

Iron Software celebrates its 10th anniversary at a moment that validates its founding thesis. Since 2015, the company has grown from a single PDF library into a comprehensive suite of .NET document processing tools used by thousands of enterprise customers worldwide.

Deloitte predicts that by 2028, 33% of enterprise software applications will include agentic AI, compared to less than 1% in 2024. Separately, Deloitte forecasts that as many as 75% of companies may invest in agentic AI by the end of 2026. PwC identifies functions like “finance, HR, IT, tax, and internal audit” as areas especially ripe for agent deployment—all functions that routinely involve the kind of document creation, extraction, and processing that IronPDF and the broader Iron Software suite are built to handle.

“Ten years ago, we made a bet that developers would always need high-quality libraries for document processing,” said Cameron Rimington, CEO of Iron Software. “We didn’t predict the AI revolution. But we did predict that enterprises would always need to create PDFs, extract text from images, and manipulate spreadsheets. Now AI agents need to do all of those same things. PwC’s report makes clear that ‘technology delivers only about 20% of an initiative’s value.’ The other 80% comes from redesigning work around tools that actually perform. That’s what we’ve spent a decade perfecting.”

On the Ground: How Enterprises Are Already Building

The reports’ findings align with what enterprise technology leaders are already experiencing. Glenn Le Marchant, Head of Technology Strategy at PKF Australia and founder of QWERTY Software Solutions, recently built an automated document processing solution by orchestrating Iron Software libraries alongside traditional code—and found that senior stakeholders assumed it was powered by AI.

“Companies are trying to use large language models to replace human intelligence and automate business processes, but that is the wrong approach,” said Le Marchant, who spent 18 years at Commonwealth Bank in senior technology roles before joining PKF. “AI is best used as one tool within a toolkit to re-engineer processes and automate them. Chaining together tools such as IronPDF, IronOCR, AI, and traditional code like API calls and rules engines, allows businesses to streamline and automate processes and orchestrate information across systems.”

Le Marchant’s experience illustrates a key theme from both reports: the most effective enterprise automation doesn’t come from AI alone—it comes from intelligent orchestration of the right tools. As AI agents increasingly enter these workflows, they will depend on the same proven libraries that are already delivering results today.

.NET Developers: More Essential Than Ever

Iron Software saw the convergence of AI and .NET development firsthand at .NET Conf 2025, the annual Microsoft developer conference held November 11–13, 2025, which Iron Software sponsored again this year. The event’s agenda was heavily focused on AI, featuring keynote sessions on agentic development, the Model Context Protocol (MCP), AI-powered development with GitHub Copilot, and building intelligent applications with .NET—a clear signal that the .NET ecosystem is positioning itself at the center of the enterprise AI buildout.

“The rise of agentic AI doesn’t diminish the role of .NET developers—it elevates it,” said Cameron Rimington, CEO of Iron Software. “.NET developers are still essential. They’re the ones building, integrating, and overseeing the systems that AI agents operate within. What’s changing is that with the right tools—like IronPDF and our broader suite—those developers can now move quicker and achieve more than ever before. A workflow that once took a team days to build and test can now be orchestrated in hours. The developer isn’t being replaced. They’re being supercharged.”

Enterprise-Ready Means AI-Ready

IronPDF and the Iron Software suite are already integrated into tens of thousands of production environments across financial services, healthcare, legal, and government. The libraries support .NET 10, run across Windows, Linux, macOS, and containerized environments including Docker and Azure, and are designed with the programmatic accessibility that agentic architectures demand. For developers building AI-powered workflows, the path from HTML to PDF in C# through IronPDF is already a well-documented, production-proven capability—not an experiment.

“The AI industry is learning what enterprise software developers have always known,” said Jacob Mellor, CTO of Iron Software. “Processing a PDF correctly every single time, handling edge cases in OCR, maintaining backwards compatibility across framework versions—these aren’t glamorous problems. But they are exactly the problems AI agents will encounter the moment they start doing real work. Deloitte notes that ‘the infrastructure built for cloud-first strategies can’t handle AI economics.’ We agree. That’s why we’ve always built our tools for the demands of production, not the convenience of demos.”

Looking Ahead

As the agentic AI market matures throughout 2026, Iron Software plans to continue investing in developer experience, cross-platform reliability, and seamless integration with AI-driven workflows. The company’s roadmap includes enhancements to IronPDF and the broader suite designed to optimize performance in automated, high-throughput environments where AI agents orchestrate complex document pipelines.

About Iron Software

Iron Software, headquartered in Chicago develops professional-grade .NET libraries for document processing. Celebrating its 10th anniversary in 2025, the company’s product suite includes IronPDF, IronOCR, IronXL, IronBarcode, IronWord, IronZIP, and other tools trusted by enterprise developers globally. IronPDF is the leading library for HTML to PDF in C# and .NET applications. Learn more at ironsoftware.com.

Source: Deloitte Tech Trends 2026 | Source: PwC 2026 AI Business Predictions

Global Times: China’s No.1 central document in starting year of 15th Five-Year Plan sets agricultural modernization roadmap, turning rural potential into growth momentum

BEIJING, Feb. 5, 2026 /PRNewswire/ — China unveiled its “No.1 central document” for 2026 on Tuesday, outlining plans to advance agricultural and rural modernization and to promote all-around rural revitalization, according to the Xinhua News Agency.

As the first major policy document on agriculture and rural affairs issued at the start of the 15th Five-Year Plan period (2026-30), analysts said the document is expected to help translate the vast potential of agriculture and rural areas into concrete drivers of economic growth and high-quality development.

This marks the 14th No.1 central document focusing on agriculture and rural work since the 18th National Congress of the Communist Party of China in 2012. As the first policy statement released by central authorities each year, the document is widely seen as a barometer of policy priorities.

According to Xinhua, the document consists of six sections covering efforts to enhance agricultural production capacity and efficiency, implement normalized and targeted assistance, promote steady income growth for farmers, advance livable and business-friendly rural development, enhance institutional innovation, and strengthen the Party’s leadership over agriculture, rural areas and farmers.

The document notes that the 15th Five-Year Plan period is a critical stage for laying the foundation for basically realizing socialist modernization, calling for efforts to shore up weak links in agriculture and rural areas, and secure faster progress in building up China’s strength in agriculture.

Among the key highlights, the document places particular emphasis on boosting comprehensive agricultural production capacity and quality efficiency, and for the first time makes systematic arrangements for implementing normalized and targeted assistance.

Chinese economists said the document sets higher development benchmarks while strengthening baseline safeguards through a system-wide modernization approach, helping lay a solid foundation for accelerating agricultural and rural modernization during the 15th Five-Year Plan period and supporting high-quality growth and domestic demand.

Boosting food security through technology

The document calls for improving the effectiveness of policies that strengthen agriculture, benefit farmers and promote rural prosperity, while firmly safeguarding national food security and upgrading rural industries. It also stresses efforts to build agriculture into a modernized major industry and improve farmers’ livelihoods, providing support for Chinese modernization, according to Xinhua.

By anchoring agricultural development firmly in modernization, the document sets a high bar even by international standards and reflects policymakers’ determination to advance agricultural and rural modernization through systemic reform, said Hu Qimu, deputy secretary-general of the Forum 50 for Digital-Real Economies Integration.

“The goal goes beyond agricultural output, aiming to build a coordinated framework linking population mobility, rural development and industrial growth,” Hu told the Global Times on Tuesday.

Food security remains the top priority and a firm red line, according to the document. It sets a target of keeping grain output at around 1.4 trillion jin (700 million tons), providing a clear benchmark for the first year of the 15th Five-Year Plan period and underscoring China’s resolve to keep its food supply firmly in its own hands.

The document sets out new measures to stabilize grain and edible oil production, including stepping up a new round of the 50-million-ton grain capacity enhancement program and promoting integrated use of farmland, seeds, machinery and farming techniques to raise yields at scale.

Zhao Changbao, director of the Rural Economy Research Center at the Ministry of Agriculture and Rural Affairs, said boosting per-unit yields of major grain and oil crops is key to strengthening food security, improving the match between supply and demand, and supporting farmers’ income growth, CCTV reported on Tuesday.

Wang Gangyi, a professor at Northeast Agricultural University, told the Global Times that technology – including bio-breeding, AI and digital technologies – has become the key variable and the critical breakthrough for raising grain output under resource constraints in China.

These priorities are translated into concrete measures in the document, which calls for accelerating the breeding and promotion of breakthrough crop varieties, expanding applications of drones, the Internet of Things and robotics, and ensuring agricultural technologies reach villages.

Official data show that China’s contribution rate of agricultural science and technology progress exceeds 64 percent, and independently bred crop varieties account for more than 95 percent of planted areas.

Normalized targeted assistance

Another major highlight is the call to implement normalized and targeted assistance, marking the first time the No.1 central document has made systematic arrangements for this policy.

The move reflects the evolving policy needs. Although China achieved decisive success in poverty alleviation in 2020 and consolidated the results through a five-year transition period, risks of falling back into poverty remain, making it necessary to shift support measures from temporary arrangements to a normalized and institutionalized framework, members of the document’s drafting group said, according to a Xinhua report.

The document outlines measures to improve the policy system for normalized assistance, enhance monitoring precision and timeliness, strengthen industrial and employment-based support, and provide differentiated assistance to underdeveloped regions. It also incorporates normalized assistance into the overall rural revitalization strategy, while maintaining policy stability in fiscal input, financial support and resource allocation.

Hu said the policy shift reflects a move toward more focused and efficient support as rural industrial foundations and farmers’ income-generating capacity improve, providing stronger institutional safeguards for consolidating poverty alleviation gains.

In addition to these key measures, the document also stresses promoting steady income growth for farmers through coordinated policies on prices, subsidies and insurance, fostering county-level industries and stabilizing employment for migrant workers.

As the first major sector-specific policy released in the 15th Five-Year Plan period (2026-30), the document aims to systematically turn rural potential into tangible growth momentum, income gains and jobs, Hu added.

More broadly, experts noted that while the document focuses on agriculture and rural affairs, it carries wider economic implications. With China’s urbanization rate at 67.89 percent, boosting rural incomes and development capacity is key to expanding domestic demand and supporting the unified national market.